We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

HospiMedica

Download Mobile App
Recent News AI Critical Care Surgical Techniques Patient Care Medical Imaging Health IT Point of Care Business Focus

Suboptimal Weight Affects Survival in Cervical Cancer

By HospiMedica International staff writers
Posted on 05 May 2016
Both overweight and underweight women with cervical cancer did not live as long as their normal-weight counterparts, according to a new study.

Researchers at the University of Cincinnati (OH, USA) and the University of North Carolina (UNC; Chapel Hill, USA) conducted a retrospective cohort study of 623 women with cervical cancer treated from July 2000 to March 2013, classifying the women according to their body mass index (BMI). In all, 4% of the women were underweight, 30% were normal weight, and 66% were overweight or obese. The primary outcome was overall survival; secondary outcomes included stage, histopathology, disease-specific survival (DSS), and recurrence free survival (RFS).

The results showed that the median overall survival time in overweight or obese women was six months shorter than in women of normal weight (22 versus 28 months); for underweight women, median overall survival time was cut in half (14 versus 28 months). There was no difference in age, stage at presentation, grade, or histology between weight categories. After controlling for prognostic factors, underweight and overweight/obese patients had worse median RFS than normal weight patients. The study was published on April 14, 2016, in in Gynecologic Oncology.

“In understanding the effect of BMI on cervical cancer outcomes, it is important to recognize that both extremes of weight appear to negatively impact survival. A potential unifying hypothesis connecting both extremes of weight to poor cancer prognosis is chronic systemic inflammation,” wrote lead author Leslie Clark, MD, of UNC, and colleagues. “Both patients with cancer cachexia/sarcopenia and overweight/obese patients are in a heightened inflammatory state, which may lead to increased cell proliferation and inhibition of apoptosis.”

"However, this is likely not the only mechanism of poor outcomes. Co-morbid medical conditions might account for some of the differences in survival, particularly in morbidly obese patients,” concluded the authors. “Providers should optimize weight in underweight and overweight/obese patients to attempt to improve outcomes in these women. Interventions that target nutritional counseling and physical activity should be explored in these populations.”

Related Links:
University of Cincinnati
University of North Carolina
Gold Member
12-Channel ECG
CM1200B
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Digital Radiography System (Ceiling Free)
Digix CF Series
Multi-Chamber Washer-Disinfector
WD 390

Channels

Medical Imaging

view channel
Image: A preclinical rabbit model undergoing longitudinal ocular vascular monitoring before and after induced optic nerve injury (upper panel) and a clinical cohort including patients with cervical lymph nodes of different pathological types (bottom panel) were used to demonstrate the generalizability of the framework. The experimental procedures for both studies include ultrasound data acquisition and reconstruction, extraction and analysis of vascular biomarkers, and construction of diagnostic models. The hierarchical edge-bundling diagram (right) illustrates relationships among ocular biomarkers. Each circular leaf node represents a specific biomarker measured in a particular vascular structure. Node size is proportional to the magnitude of the statistically significant difference observed for that biomarker in this study; larger nodes indicate a greater statistically significant difference. (Photo courtesy of XUEJUN Lab@ShanghaiTech)

Automated Platform Converts Super-Resolution Ultrasound into Vascular Biomarkers

Microvascular dysfunction, an early marker of glaucoma, cancer, and other systemic illnesses, often precedes overt clinical signs yet remains difficult to quantify deep in tissue. Super-resolution ultrasound... Read more

Business

view channel
Image: Sempresto’s Smartphone-Integrated Epinephrine Auto-Injector Wins Red Dot Design Award (Photo courtesy of Sempresto)

Smartphone-Integrated Epinephrine Auto-Injector Concept Wins Red Dot Design Award

Severe allergic reactions can escalate rapidly and require prompt epinephrine, yet many at-risk patients do not consistently carry their auto-injector. With food allergies affecting an estimated 220 million... Read more